Tonghua Dongbao Pharmaceutical Co LtdControlling shareholder pledges 93.94% of holdings, signaling financial strain and potential share overhang.

Tonghua Dongbao's controlling shareholder, Dongbao Group, carried out a release-and-re-pledge operation involving 32 million shares. According to an August 12 announcement, Dongbao Group released the pledge on 32 million shares, representing 5.17% of its holdings and 1.63% of the company's total share capital, while simultaneously re-pledging the same number of shares. As of the announcement date, Dongbao Group's cumulative pledged shares reached 582 million shares, accounting for 93.94% of its holdings and 29.71% of the company's total share capital. In the first quarter of 2026, the company achieved revenue of 748 million yuan and net profit attributable to the parent company of 127 million yuan.
Tonghua Dongbao Pharmaceutical Co LtdControlling shareholder pledges 93.94% of holdings, signaling financial strain and potential share overhang.